This is an exciting and important method of ascertaining and ensur- ing patient education with regard to their perceived outcomes of PCI. The writing committee did not support including this as a measure because the outcomes of PCI vary according to presenting symptoms; for example, patients with an acute myocardial infarction could have an improved risk of mortal- ity as a result of their PCI, but patients undergoing elective PCI for chronic stable angina probably have no improvement in their outcome other than symptom relief. Staff American College of Cardiology John Gordon Harold, MD, MACC, FAHA, President Shalom Jacobovitz, Chief Executive Officer William J. Oetgen, MD, MBA, FACC, Executive Vice President, Science, Education, and Quality Charlene L. May, Senior Director, Science and Clinical Policy Melanie Shahriary, RN, BSN, Director, Performance Measures and Data Standards American College of Cardiology/American Heart Association Naira Tahir, MPH, Specialist, Clinical Performance Measures American Heart Association Mariell Jessup, MD, FACC, FAHA, President Nancy Brown, Chief Executive Officer Rose Marie Robertson, MD, FACC, FAHA, FESC, Chief Science Officer Gayle R. Whitman, PhD, RN, FAHA, FAAN, Senior Vice President, Office of Science Operations Melanie B. Turner, MPH, Science and Medicine Advisor, Office of Science Operations Jody Hundley, Production Manager, Scientific Publishing, Office of Science Operations American Medical Association Physician Consortium for Performance Improvement Mark Antman, DDS, MBA, Director, Measure Development Operations Kendra Hanley, MS, Project Manager II, Measure Specifications, Standards, and Informatics Karen Kmetik, PhD,Vice President, Performance Improvement Marjorie Rallins, DPM, Director, Measure Specifications, Standards, and Informatics Samantha Tierney, MPH, Project Manager II, Measure Development Operations Gregory Wozniak, PhD, Director, Measure Analytics and Economic Evaluation Society for Cardiovascular Angiography and Interventions Wayne Powell, Senior Director for Advocacy & Guidelines Joel Harder, MBA, Director of Quality Initiatives and Clinical Documents References 1. 